Intercept Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch ICPT and buy or sell other stocks, ETFs, and their options commission-free!

About ICPT

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes OCALIVA, which is used for the treatment of biliary cholangitis, nonalcoholic steatohepatitis, sclerosing cholangitis and biliary atresia.

CEO

Jerome B. Durso

CEOJerome B. Durso

Employees

—

Employees—

Headquarters

Morristown, New Jersey

HeadquartersMorristown, New Jersey

Founded

2002

Founded2002

Employees

—

Employees—

ICPT Key Statistics

Market cap

794.69M

Market cap794.69M

Price-Earnings ratio

-13.58

Price-Earnings ratio-13.58

Dividend yield

—

Dividend yield—

Average volume

841.73K

Average volume841.73K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$21.86

52 Week high$21.86

52 Week low

$8.82

52 Week low$8.82

People also own

Based on the portfolios of people who own ICPT. This list is generated using Robinhood data, and it’s not a recommendation.